Clinical Edge Journal Scan

Clinical Edge Journal Scan

Commentary: COVID-19 Treatment and Disease-Modifying Therapies in MS, June 2022

Author:: Mark Gudesblatt, MD

Publish date: May 27, 2022

Read More

Clinical Edge Journal Scan

Multiple sclerosis type and female sex predict worsening lower urinary tract symptoms

Publish date: May 18, 2022

Read More

Clinical Edge Journal Scan

Multiple sclerosis: Reduced humoral response contributes to breakthrough SARS-CoV-2 infection in patients on DMTs

Publish date: May 18, 2022

Read More

Clinical Edge Journal Scan

T-cell response after third SARS-CoV-2 vaccination in patients with MS on ocrelizumab

Publish date: May 18, 2022

Read More

Clinical Edge Journal Scan

Long-term treatment with siponimod is effective and safe in SPMS

Publish date: May 18, 2022

Read More

Clinical Edge Journal Scan

Teriflunomide effective and well-tolerated in patients with RRMS

Publish date: May 18, 2022

Read More

Clinical Edge Journal Scan

Multiple sclerosis: Greater prevalence of disease activity in women and disability accrual in men

Publish date: May 18, 2022

Read More

Clinical Edge Journal Scan

RRMS: Long-term fingolimod shows positive benefit-risk profile in real-life settings

Publish date: May 18, 2022

Read More

Clinical Edge Journal Scan

Anti-SARS-CoV-2 mAbs safe and effective for acute COVID-19 in immunocompromised patients with MS

Publish date: May 18, 2022

Read More

Clinical Edge Journal Scan

Progressive MS: sNfL shows promise as an effective biomarker for long-term disability progression

Publish date: May 18, 2022

Read More

Pages

FULL MENU FULL MENU
More
- MDedge Neurology